Angiotensin1-9 antagonises pro-hypertrophic signalling in cardiomyocytes via the angiotensin type 2 receptor

Angiotensin-(1–9) regulates cardiac hypertrophy in vivo and in vitro

(2010) Maria Paz Ocaranza et al.   JOURNAL OF HYPERTENSION

Genetic deletion of the angiotensin-(1–7) receptor Mas leads to glomerular hyperfiltration and microalbuminuria

(2009) Sérgio V.B. Pinheiro et al.   KIDNEY INTERNATIONAL

What systems can and can't do

(2008) T Kenakin   BRITISH JOURNAL OF PHARMACOLOGY

Angiotensin(1-7) Blunts Hypertensive Cardiac Remodeling by a Direct Effect on the Heart

(2008) Chantal Mercure et al.   CIRCULATION RESEARCH

Distinct roles for angiotensin-converting enzyme 2 and carboxypeptidase A in the processing of angiotensins within the murine heart

(2008) Paul J. Garabelli et al.   EXPERIMENTAL PHYSIOLOGY

Molecular Mechanisms Involved in the Angiotensin-(1-7)/Mas Signaling Pathway in Cardiomyocytes

(2008) Marco F. Dias-Peixoto et al.   HYPERTENSION

Angiotensin II: A hormone involved in and contributing to pro-hypertrophic cardiac networks and target of anti-hypertrophic cross-talks

(2008) K.-D. Schlüter et al.   PHARMACOLOGY & THERAPEUTICS

Opposite effects of angiotensin II and angiotensin (1–7) on impulse propagation, excitability and cardiac arrhythmias. Is the overexpression of ACE2 arrhythmogenic?

(2008) Walmor C. De Mello   REGULATORY PEPTIDES

Angiotensin II-induced vasodilation via type 2 receptor: Role of bradykinin and nitric oxide

(2007) Katsutoshi Yayama et al.   INTERNATIONAL IMMUNOPHARMACOLOGY